POET Technologies: Premium $400M Placement Can't Mask Fallout From Marvell Fallout and Litigation Wave

POET Technologies raised $400M in a premium direct placement, but shares fell 22.4% as investors react to a canceled Marvell order, class-action lawsuits, and executive changes.

POET Technologies pulled off a rare feat: it raised $400 million in a direct placement at a price above its prior close. But the optics of that premium were quickly overwhelmed by a 22.4% plunge to $15.97 on Friday, as investors weighed the capital infusion against a canceled flagship order, a cascade of class-action suits and an executive exit.

The placement, announced May 15, sees a single institutional investor buying units at $21.00 each. Each unit consists of one common share and one warrant exercisable at $26.15. The offering price sat above the previous day's close of $20.57, a signal that the company's financing team secured better-than-market terms. Roughly 19.05 million shares and an equal number of warrants will hit the float, diluting existing holders but also injecting the cash POET needs to stabilise its balance sheet, expand manufacturing capacity and accelerate its light-source business.

The dilution sting is sharp, but the wider market's pessimism has deeper roots. In late April, Marvell Semiconductor's Celestial AI unit terminated all purchase orders after accusing POET of improperly disclosing confidential supply volumes. The stock crashed more than 47% on the news. That order book was central to POET's commercialisation story, and losing it left a hole that not even the new $400 million can easily fill.

Lawyers have piled on. Multiple shareholder class actions allege that a manager violated a confidentiality agreement tied to the Marvell relationship. The lawsuits also target disclosures around POET's tax status and its financial reporting. The deadline for lead plaintiff applications is June 29, 2026, giving investors more than a year to organise. The legal overhang adds another layer of uncertainty to a stock already under heavy pressure.

Management is shuffling the deck in response. Sandeep Kumar has been appointed chief operating officer. Meanwhile, veteran CFO Thomas Mika has announced his planned retirement in 2026, and the board has launched a search for his successor — a process that also dovetails with a proposed relocation of the company's headquarters to the United States. A shareholder vote on the move is scheduled for the June 26 annual meeting, a step designed to prevent POET from being classified as a passive foreign investment company (PFIC) under U.S. tax rules.

The financials underscore how early POET's commercialisation still is. First-quarter revenue more than tripled year-over-year to $503,389, but that's from a negligible base. The net loss widened to $12.3 million, or $0.08 per share, worse than the $0.04–$0.05 analysts had pencilled in. Research and development spending ran at $4.5 million, and operating cash burn approached $9 million. The new capital will help bridge that gap, but it also buys time for POET to prove its optical semiconductor platform can attract reliable customers beyond the now-broken Marvell relationship.

One bright spot: the Lumilens partnership. POET landed a hardware order worth $50 million from Lumilens, with a potential total addressable volume of more than $500 million over five years. The deal is small in the context of the $400 million raise, but it points to a commercial pipeline that could eventually replace the lost Marvell business.

Short-term trading dynamics add volatility. A new leveraged ETF from Defiance ETFs, ticker POEL, has magnified daily swings. The stock is now hovering near technical support at $15.53, with a recovery above $20 seen as the first sign of stabilisation. All eyes are on Monday, May 18, when the direct placement is expected to close. That milestone will mark the end of the fundraising leg — but the trust-deficit leg still has a long road ahead.